Rhythm

HeartSciences Named Among ‘50 Smartest Companies of the Year 2018’ by The Silicon Review Magazine

SOUTHLAKE, Texas–(BUSINESS WIRE)–Silicon Review, a leading Business and Technology magazine has named HeartSciences, as one of the 50 Smartest Companies of the Year 2018. “The Silicon Review 50 Smartest Companies of the Year 2018 program identifies companies that mastered the discipline of smartness and stood high among the crowd,” said Sreshtha Banerjee, Editor-in-Chief […]

AtriCure Announces Completion of Patient Enrollment in the CONVERGE IDE Clinical Trial

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced it has completed enrollment of the full cohort of 153 patients in the CONVERGE IDE clinical trial. The CONVERGE IDE trial is a landmark prospective, randomized trial […]

Daiichi Sankyo Presents First Snapshot Analyses from Global ETNA-AF Programme of Oral, Once-daily LIXIANA®▼ (edoxaban) in Patients with Nonvalvular Atrial Fibrillation in Routine Clinical Practice

MUNICH, Aug. 28, 2018 /PRNewswire/ — The Global ETNA-AF programme is a large and comprehensive single non-vitamin K oral anticoagulant (NOAC) repository of real-world data, as part of the Edoxaban Clinical Research Programme, EDOSURE Three snapshot analyses from baseline data add to growing evidence of the use of edoxaban in the real-world […]

Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon

DUBLIN and MUNICH – August 28, 2018 – Medtronic plc (NYSE:MDT) today announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions and repeat ablation procedures. The study evaluated patients with symptomatic persistent atrial fibrillation (AF) […]

InfoBionic Signs BIOTRONIK as Exclusive U.S. Distributor for MoMe® Kardia

BOSTON–(BUSINESS WIRE)–InfoBionic, a digital health company focused on creating next-generation solutions for ambulatory, cardiac arrhythmia monitoring, today announced an exclusive, strategic agreement with medical device manufacturer BIOTRONIK for U.S. distribution of InfoBionic’s proprietary MoMe® Kardia system, effective immediately. “BIOTRONIK is a trusted technology provider throughout the healthcare industry and we believe that […]

BIOTRONIK Advances Arrhythmia Detection and Diagnosis with MoMe Cardiac Monitor in the US

LAKE OSWEGO, Ore., Aug. 27, 2018 /PRNewswire/ — BIOTRONIK today announced that the company is now the exclusive US distributor for InfoBionic’s MoMe Kardia external cardiac diagnostic monitor. The device benefits patients suspected of experiencing cardiac arrhythmias. Patients experiencing cardiac arrhythmias face an increased risk of personal injury from falls, motor vehicle accidents, stroke […]

USX Denali Expedition Successfully Obtains High-Altitude Cardiac Data Using Cardiac Insight, Inc. Wearable ECG Sensor, Cardea SOLO™

KIRKLAND, Wash.–(BUSINESS WIRE)–You love the outdoors – but your heart might not. If you enjoy skiing, hiking and other sports experienced at high altitudes, you might be well advised to spend your first day at altitude taking it easy. In older men, especially those unaccustomed to intense physical exertion and […]

BioSig Technologies to Present at the MicroCap Leadership Summit

Santa Monica, CA, Aug. 22, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that it has been selected to present at the third annual […]

AtriCure to Present at the Morgan Stanley Global Healthcare Conference

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will present at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt Hotel in New York on Friday, September 14, 2018. Management is scheduled to present […]

HeartSciences Showcases MyoVista® Wavelet ECG at 2018 European Society of Cardiology Congress (ESC)

SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, a medical device company developing next generation ECG devices using continuous wavelet transform (CWT) signal processing and artificial intelligence, is proud to announce its participation as an exhibitor at the upcoming 2018 European Society of Cardiology Congress (ESC). The Congress will take place at Messe Munich International […]